Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.527EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.500EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.487EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.121EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AA.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AS.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.115EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.127.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.88EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.422EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.198EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.366EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.441EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.416EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.219EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.208EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.125.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.78 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.159EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.5 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.443EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.168EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.57EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.289EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.365EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.252EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used